NCT00611169View on ClinicalTrials.gov

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

August 31, 2007

Conditions
Acute Myocardial Infarction
Interventions
DRUG

tirofiban

tirofiban (25 μg/kg bolus and 0.15 μg/kg/min maintenance infusion for 24 hours)

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00611169 - The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter